HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Postel-Vinay, M.-C. Articles by Finidori, J. Search for Related Content PubMed Articles by Postel-Vinay, M.-C. Articles by Finidori, J.

Growth hormone receptor: structure and signal transduction

Postel-Vinay M-C, Finidori J. Growth hormone receptor: structure and signal transduction. Eur J Endocrinol 1995;133:654–9. ISSN 0804–4643

The growth hormone receptor (GHR) belongs to the superfamily of transmembrane proteins that includes the prolactin receptor and a number of cytokine receptors. Two forms exist for the GHR: the full-length membrane-bound human receptor is a protein of 620 amino acids with a single transmembrane region; and the GH binding protein (GHBP) is a short soluble form corresponding to the extracellular domain of the full-length receptor. In rodents, GHBP is encoded by a specific mRNA of 1.2–1.5 kb, whereas in man and other species GHBP is believed to result from proteolytic cleavage of the membrane receptor. Growth hormone binding protein prolongs the half-life of GH but other functions for GHBP remain to be demonstrated. Recombinant GHBP complexed to human GH shows a 2:1 stoichiometric crystal structure. Growth hormone-induced dimerization of the cell surface GHR appears to be a prerequisite for biological activity of the hormone. JAK2 has been identified as a tyrosine kinase associated with GHR and other receptors of the superfamily. Binding of GH to its receptor results in dimerization of the GHR, phosphorylation of JAK2 and of the GHR. Other substrates for JAK2 have to be identified. Transcription factors belonging to the STAT (signal transducers and activators of transcriptions) family are involved in the transcriptional effects of GH. The activity of mutants of the GHR has been measured in functional tests to identify sequences of the cytoplasmic domain of the receptor that are important for signal transduction. A proline-rich sequence, called Box I, conserved among members of the receptor family has been shown to be crucial for GH effects on gene transcription, MAP kinase activity and cell proliferation. The C-terminal region of the GHR is required for tyrosine phosphorylation of the receptor and for a hormonal effect on gene transcription, whereas only 46 membrane proximal amino acids of the cytoplasmic domain are necessary for activation of JAK2 and transduction of the GH proliferative signal. Much work remains to be done to identify other protein kinases and signalling molecules involved in the mechanism of action of GH.

M-C Postel-Vinay, INSERM Unité 344, Faculté de Médecine Necker, 156 rue de Vaugirard, 75730 Paris Cedex 15, France

This article has been cited by other articles:

				C. Pasquali, M.-L. Curchod, S. Walchli, X. Espanel, M. Guerrier, F. Arigoni, G. Strous, and R. H. van Huijsduijnen Identification of Protein Tyrosine Phosphatases with Specificity for the Ligand-Activated Growth Hormone Receptor Mol. Endocrinol., November 1, 2003; 17(11): 2228 - 2239. [Abstract] [Full Text] [PDF]

				L. G. Sheffield and J. J. Gavinski Proteomics Methods for Probing Molecular Mechanisms in Signal Transduction J Dairy Sci, July 1, 2003; 86(13_suppl): E115 - 124. [Abstract] [Full Text] [PDF]

				L. G. Sheffield and J. J. Gavinski Proteomics methods for probing molecular mechanisms in signal transduction J Anim Sci, March 1, 2003; 81(suppl_3): 48 - 57. [Abstract] [Full Text] [PDF]

				M. Salerno, B. Balestrieri, E. Matrecano, A. Officioso, R. G. Rosenfeld, S. Di Maio, G. Fimiani, M. V. Ursini, and C. Pignata Abnormal GH Receptor Signaling in Children with Idiopathic Short Stature J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3882 - 3888. [Abstract] [Full Text] [PDF]

				K. Lewandowski, R. Horn, C. J. O’Callaghan, D. Dunlop, G. F. Medley, P. O’Hare, and G. Brabant Free Leptin, Bound Leptin, and Soluble Leptin Receptor in Normal and Diabetic Pregnancies J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 300 - 306. [Abstract] [Full Text]

				R. J. M. Ross, N. Esposito, X. Y. Shen, S. Von Laue, S. L. Chew, P. R. M. Dobson, M.-C. Postel-Vinay, and J. Finidori A Short Isoform of the Human Growth Hormone Receptor Functions as a Dominant Negative Inhibitor of the Full-Length Receptor and Generates Large Amounts of Binding Protein Mol. Endocrinol., March 1, 1997; 11(3): 265 - 273. [Abstract] [Full Text]

				J. S. Freeth, R. M. Ayling, A. J. Whatmore, P. Towner, D. A. Price, M. R. Norman, and P. E. Clayton Human Skin Fibroblasts as a Model of Growth Hormone (GH) Action in GH Receptor-Positive Laron's Syndrome Endocrinology, January 1, 1997; 138(1): 55 - 61. [Abstract] [Full Text] [PDF]